Garuda Therapeutics

Garuda Therapeutics

  • Founded: 2021
  • Location: Cambridge, MA
  • Employee range: 11 - 50
  • Clinical stage: RD/Clin0
  • Therapy area: Transfusion-dependent beta-thalassemia
  • Drug types: HEM, GEN, BON
  • Lead product: Undisclosed
  • Product link:
  • Funding: $62M B Feb 2023; $72M A Sep 2021
  • Investors: Northpond Ventures, OrbiMed Advisors, Cormorant Asset Management, Aisling Capital, Sectoral Asset Management, Mass General Brigham Ventures, Alexandria Venture Investments

job board

Short description:

Off-the-shelf hematopoietic stem cell therapies

Drug notes:

Undisclosed RD/Clin0 bone marrow failure

Long description:

Garuda Therapeutics is developing “off-the-shelf”, durable blood stem cell therapies to treat a range of diseases. Hematopoietic stem cells (HSCs) can be used to generate many different blood cell types from immune cells to red blood cells. HSCs also self renew. Currently, patients seeking a blood stem cell transplant must find a suitable donor which can place greater barriers for racial minority patients. As an alternative solution, Garuda is using their platform to generate “off-the-shelf” self-renewing HSCs to provide patients with rapid and broad access to consistent, durable and transgene-free stem cell therapies. Garuda’s blood cells have the potential to cure more than 70 diseases and eliminate the dependency on donor cells.


Garuda Therapeutics
Cell-Based Assays Senior or Principal Scientist, A...
Cambridge, MA|23 days ago
Garuda Therapeutics
Research Associate, Analytical Development
Cambridge, MA|23 days ago
Garuda Therapeutics
Scientist or Senior Scientist, Pluripotent Stem Ce...
Cambridge, MA|100+ days ago
Garuda Therapeutics
Process Development Scientist
Cambridge, MA|100+ days ago
Garuda Therapeutics
Biomanufacturing Associate
Cambridge, MA|100+ days ago

© 2024 Work In Biotech LLC
Personal data

Terms of Service

Privacy Policy